Malaga Cove Capital’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.81M Sell
1,506
-61
-4% -$62.3K 0.58% 45
2026
Q1
$1.44M Buy
1,567
+407
+35% +$413K 0.52% 54
2025
Q4
$1.25M Sell
1,160
-50
-4% -$47.8K 0.43% 72
2025
Q3
$923K Buy
1,210
+848
+234% +$631K 0.34% 86
2025
Q2
$282K Buy
+362
New +$281K 0.11% 150

Other funds holding LLY

Malaga Cove Capital's LLY Position: Q2 2026 in Review

Malaga Cove Capital reduced its Eli Lilly (LLY) stake by 3.9% in Q2 2026, selling an estimated $62.3K and leaving 1,506 shares worth $1.81M. The position accounts for 0.58% of the portfolio, ranked #45.

Malaga Cove Capital first reported a position in LLY in Q2 2025 and has held it in 5 quarters since. 4,618 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Malaga Cove Capital held 1,506 shares of Eli Lilly worth $1.81M as of Q2 2026.
  • Malaga Cove Capital sold 61 Eli Lilly shares in Q2 2026, an estimated $62.3K.
  • Eli Lilly made up 0.58% of Malaga Cove Capital's portfolio in Q2 2026, its #45 holding.
  • Malaga Cove Capital first reported a position in Eli Lilly in Q2 2025 and has held it in 5 quarters since.
  • 4,618 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Malaga Cove Capital's 13F filing for Q2 2026, filed 24 Jul 2026.